NCT04921332

Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD

Effect of Bright Light Therapy on Depression Symptoms in Adult Inpatients With Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD)

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 4 (actual)
• Sponsor: Erica Osborn · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a project that will determine whether the use of daily bright light therapy has an effect on depressive symptoms experienced by adult inpatients with CF and COPD. The purpose of this project is to apply a daily 30-minute BLT intervention to hospitalized adult CF and COPD patients in order to decrease symptoms of depression as measured by depression inventory scoring.

Detailed description

This project will occur on a 29-bed pulmonary step-down unit at a 1,600-bed academic medical center. This unit commonly treats patients with CF, COPD, and other pulmonary complications. The unit's patient care staff will be educated on the bright light lamps in order to prevent interruptions and to encourage compliance.

Conditions

• Cystic Fibrosis
• Depressive Symptoms
• Chronic Obstructive Pulmonary Disease

Interventions

Type	Name	Description
DEVICE	Bright Light Therapy (BLT) Lamp	With its built in automatic timer shut-off function, the bedside registered nurse (RN) would not need to return to the room to turn off this lamp after 30 minutes because the lamp will automatically shut off on its own.

Timeline

• Start date: 2021-09-07
• Primary completion: 2022-03-22
• Completion: 2022-03-22
• First posted: 2021-06-10
• Last updated: 2023-02-28
• Results posted: 2023-02-28

Locations

2 sites across 1 country: United States

Regulatory

• FDA-regulated device study